Human Serum Albumin Aggregation/Fibrillation and its Abilities to Drugs Binding

Autor: Agnieszka Szkudlarek, Karolina Kulig, Jadwiga Pożycka, Wojciech Rogóż, M. Maciążek-Jurczyk, Kamil Janas, Aleksandra Owczarzy
Rok vydání: 2020
Předmět:
Circular dichroism
Pharmaceutical Science
02 engineering and technology
Ligands
Analytical Chemistry
chemistry.chemical_compound
Drug Discovery
Dansyl Compounds
aggregation/fibrillation
0303 health sciences
spectroscopic methods
021001 nanoscience & nanotechnology
Human serum albumin
Phenylbutazone
Ketoprofen
human serum albumin
Chemistry (miscellaneous)
embryonic structures
Molecular Medicine
Thioflavin
0210 nano-technology
Protein Binding
medicine.drug
Amyloid
Proline
Serum Albumin
Human

complex mixtures
Article
Fluorescence
Fluorescence spectroscopy
lcsh:QD241-441
03 medical and health sciences
lcsh:Organic chemistry
Prohibitins
medicine
Humans
Physical and Theoretical Chemistry
Binding site
030304 developmental biology
Binding Sites
Organic Chemistry
Albumin
equipment and supplies
In vitro
body regions
Kinetics
chemistry
Biophysics
bacteria
Zdroj: Molecules, Vol 25, Iss 3, p 618 (2020)
Molecules
Volume 25
Issue 3
ISSN: 1420-3049
Popis: Human serum albumin (HSA) is a protein that transports neutral and acid ligands in the organism. Depending on the environment&rsquo
s pH conditions, HSA can take one of the five isomeric forms that change its conformation. HSA can form aggregates resembling those in vitro formed from amyloid at physiological pH (neutral and acidic). Not surprisingly, the main goal of the research was aggregation/fibrillation of HSA, the study of the physicochemical properties of formed amyloid fibrils using thioflavin T (ThT) and the analysis of ligand binding to aggregated/fibrillated albumin in the presence of dansyl-l-glutamine (dGlu), dansyl-l-proline (dPro), phenylbutazone (Phb) and ketoprofen (Ket). Solutions of human serum albumin, both non-modified and modified, were examined with the use of fluorescence, absorption and circular dichroism (CD) spectroscopy. The experiments conducted allowed observation of changes in the structure of incubated HSA (HSAINC) in relation to nonmodified HSA (HSAFR). The formed aggregates/fibrillation differed in structure from HSA monomers and dimers. Based on CD spectroscopy, previously absent &beta
structural constructs have been registered. Whereas, using fluorescence spectroscopy, the association constants differing for fresh and incubated HSA solutions in the presence of dansyl-amino acids and markers for binding sites were calculated and allowed observation of the conformational changes in HSA molecule.
Databáze: OpenAIRE